These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27737864)

  • 1. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
    Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
    Ocak G; Roest M; Verhaar MC; Rookmaaker MB; Blankestijn PJ; Bos WJW; Fijnheer R; Péquériaux NC; Dekker FW
    BMC Nephrol; 2021 Jun; 22(1):222. PubMed ID: 34134634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
    Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
    Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study.
    Garam N; Maláti É; Sinkovits G; Gombos T; Szederjesi A; Barabás L; Gráf L; Kocsis J; Prohászka Z
    Thromb Haemost; 2018 Jan; 118(1):123-131. PubMed ID: 29304532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.
    Sonneveld MA; de Maat MP; Portegies ML; Kavousi M; Hofman A; Turecek PL; Rottensteiner H; Scheiflinger F; Koudstaal PJ; Ikram MA; Leebeek FW
    Blood; 2015 Dec; 126(25):2739-46. PubMed ID: 26511134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Function and Cardiovascular Disease: The Mediating Role of Coagulation Factors.
    Bano A; Chaker L; de Maat MPM; Atiq F; Kavousi M; Franco OH; Mattace-Raso FUS; Leebeek FWG; Peeters RP
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3203-3212. PubMed ID: 30938758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study.
    Sonneveld MA; Kavousi M; Ikram MA; Hofman A; Rueda Ochoa OL; Turecek PL; Franco OH; Leebeek FW; de Maat MP
    J Thromb Haemost; 2016 Nov; 14(11):2114-2120. PubMed ID: 27559008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
    Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
    Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
    Akyol O; Akyol S; Chen CH
    Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
    Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
    Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.
    Smith DR; Lim ST; Murphy SJX; Hickey FB; Offiah C; Murphy SM; Collins DR; Coughlan T; O'Neill D; Egan B; O'Donnell JS; O'Sullivan JM; McCabe DJH
    J Neurol Sci; 2024 Aug; 463():123118. PubMed ID: 39024743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.
    de Vries PS; van Herpt TT; Ligthart S; Hofman A; Ikram MA; van Hoek M; Sijbrands EJ; Franco OH; de Maat MP; Leebeek FW; Dehghan A
    Diabetologia; 2017 Feb; 60(2):280-286. PubMed ID: 27787621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
    Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.